12 results on '"Jara C"'
Search Results
2. EGFR intron 1 CA dinucleotide repeat as predictor of toxicity and efficacy in lung cancer patients treated with erlotinib
3. Phase II study of combination cetuximab and weekly paclitaxel in patients with metastatic/recurrent squamous cell carcinoma of head and neck (SCCHN): Spanish Head and Neck Cancer Group (TTCC)
4. A phase I study of erlotinib, bevacizumab and gemcitabine in patients with advanced pancreatic cancer
5. Correlation between the EGFR intron 1 CA dinucleotide repeat and skin toxicity in lung cancer patients treated with erlotinib
6. Phase III study of gemcitabine plus vinorelbine (VG) versus vinorelbine (V) in patients (pts) with metastatic breast cancer (MBC) previously treated with anthracyclines (A) and taxanes (T). Final results of GEICAM 2000–04 study
7. R-CHOP-14 in patients with diffuse large-B-cell lymphoma (DLBCL) younger than 70 years: A multicentric and prospective study
8. A randomized, phase II trial comparing sequential paclitaxel/cisplatin/gemcitabine/vinorelbine/ (PCGV) with cisplatin/gemcitabine/vinorelbine/ (CGV) in patients (pts) with advanced non-small cell lung cancer (NSCLC)
9. Phase II study of capecitabine (X) as single agent in elderly patients (p) with metastatic breast cancer (MBC): Final results
10. Capecitabine (X) as single agent in elderly patients (p) with metastatic breast cancer (MBC)
11. Phase II study of a fixed dose-rate infusion of gemcitabine associated to cisplatin and UFT in advanced carcinoma of the pancreas, an ONCOPAZ study
12. Retrorectal cystic hamartoma as benign cause of CA 19-9 elevation.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.